Table 2 Asthma prevalence by HIV and potential confounding factors
From: The impact of HIV on the prevalence of asthma in Uganda: a general population survey
n (%) | Prevalence of asthma % | Crude PR (95% CI) | p | Adjusted PRb (95% CI) | p-value | |
|---|---|---|---|---|---|---|
Characteristic | ||||||
HIV status | ||||||
Infected | 103 (5.0) | 15.5 | 1.72 (1.07–2.75) | 0.025 | 1.54 (0.94–2.51) | 0.085 |
Uninfected | 1966 (95.0) | 9.1 | Reference | Reference | ||
Gender | ||||||
Female | 1275 (61.6) | 9.9 | 1.15 (0.87–1.53) | 0.319 | 1.24 (0.92–1.68) | 0.159 |
Male | 794 (38.4) | 8.6 | Reference | Reference | ||
Smoking | ||||||
Yes | 168 (8.1) | 16.7 | 1.91 (1.32–2.76) | 0.001 | 1.79 (1.23–2.60) | 0.002 |
No | 1901 (91.9) | 8.7 | Reference | Reference | ||
Biomass use | ||||||
Yes | 409 (19.8) | 14.2 | 1.74 (1.31–2.32) | < 0.001 | 1.56 (1.18–2.07) | 0.002 |
No | 1659 (80.2) | 8.1 | Reference | Reference | ||
TB treatment | ||||||
Yes | 40 (1.9) | 22.5 | 2.46 (1.36–4.45) | 0.003 | 2.20 (1.26–3.84) | 0.005 |
No | 2026 (98.1) | 9.1 | Reference | Reference | ||
Family history of asthma | ||||||
Yes | 235 (11.4) | 23.8 | 3.16 (2.39–4.18) | < 0.001 | 2.41 (1.81–3.23) | < 0.001 |
No | 1832 (88.6) | 7.5 | Reference | Reference | ||
Allergy | ||||||
Yes | 763 (36.9) | 16.0 | 2.90 (2.20–3.83) | < 0.001 | 2.45 (1.85–3.26) | < 0.001 |
No | 1306 (63.1) | 5.5 | Reference | Reference | ||
TB/HIV (HIV infected and history of TB treatment) | ||||||
Yes | 10 (0.5) | 10.0 | 1.07 (0.17–6.89) | 0.946 | 0.20 (0.02–1.66) | 0.135 |
No | 2059 (99.5) | 9.4 | Reference | Reference | ||
Age in yearsa | 2.09 (1.52–2.88) | < 0.001 | 1.83 (1.30–2.58) | 0.001 | ||